Showing results (41-50 of 102) with videos related to
Sort By:
Pageof 11
Cancer Gene Therapy|September 24, 2005
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancersS Varghese, S D Rabkin, R Liu, et al.Cancer Gene Therapy|August 18, 2012
Treatment of breast cancer stem cells with oncolytic herpes simplex virusJ Li, W Zeng, Y Huang, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1982
Effect of acetylated and deacetylated 2-aminofluorene adducts on in vitro DNA synthesisP D Moore, S D Rabkin, A L Osborn, et al.Gene Therapy|September 1, 1994
Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectorsM J Wood, A P Byrnes, D W Pfaff, et al.Gene Therapy|January 1, 1994
Immunological consequences of HSV-1-mediated gene transfer into the CNSM J Wood, A P Byrnes, S D Rabkin, et al.Cancer Gene Therapy|November 10, 2012
Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer modelsB J Passer, T Cheema, S Wu, et al.Cancer Research|April 18, 2001
Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantationA Wu, A Mazumder, R L Martuza, et al.Cancer Gene Therapy|February 7, 2009
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cellsB J Passer, P Castelo-Branco, J S Buhrman, et al.Journal of Digital Imaging|June 10, 2000
Modality interfacing: the impact of a relay stationJ A Carrino, R Khorasani, W B Hanlon, et al.Virology|October 1, 1992
Molecular analysis of simian varicella virus DNAP Clarke, S D Rabkin, M V Inman, et al.Pageof 11